Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
13 hedge funds and large institutions have $119K invested in Altamira Therapeutics Ltd in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
8% more funds holding
Funds holding: 12 → 13 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
16% less capital invested
Capital invested by funds: $142K → $119K (-$23K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$46.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$26.9K |
| 3 |
Morgan Stanley
New York
|
+$13.4K |
| 4 |
HF
HRT Financial
New York
|
+$9.79K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$9.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$36K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.47K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$6.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $36K | +$46.5K | +280 | +875% |
|
|
2
Group One Trading
Chicago,
Illinois
| $19K | -$6.64K | -40 | -20% |
|
|
3
Citadel Advisors
Miami,
Florida
| $19K | +$26.9K | +162 | New |
|
|
4
Morgan Stanley
New York
| $17K | +$13.4K | +81 | +123% |
|
|
TSS
5
Two Sigma Securities
New York
| $7K | +$9.63K | +58 | New |
|
6
Renaissance Technologies
New York
| $6K | +$8.3K | +50 | New |
|
|
HF
7
HRT Financial
New York
| $6K | +$9.79K | +59 | New |
|
8
Geode Capital Management
Boston,
Massachusetts
| $5K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $2K | -$7.47K | -45 | -69% |
|
10
Simplex Trading
Chicago,
Illinois
| $2K | +$3.15K | +19 | New |
|
|
IC
11
Ikarian Capital
Dallas,
Texas
| – | -$36K | -188 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$11K | -57 | Closed |
|
|
13
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$9K | -47 | Closed |
|
|
VPIM
14
Vanguard Personalized Indexing Management
Oakland,
California
| – | -$5K | -26 | Closed |
|
CYTO Hedge Fund Activity: Q3 2022 in Review
13 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2022, worth a combined $119K — down 16% from $142K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CYTO positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, adding an estimated $46.5K. The largest seller was Ikarian Capital, exiting entirely with an estimated $36K sold.
- 13 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2022, up from 12 in Q2 2022.
- Funds reported $119K of Altamira Therapeutics Ltd stock for Q3 2022, down 16% quarter-over-quarter.
- 5 funds opened new Altamira Therapeutics Ltd positions in Q3 2022 and 4 closed out, a net change of +1 holder.
- The largest Altamira Therapeutics Ltd buyer in Q3 2022 was Virtu Financial, an estimated $46.5K added.
- The largest Altamira Therapeutics Ltd seller in Q3 2022 was Ikarian Capital, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2022.